ArticleOncotarget2016

A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers.

Sandra Hocke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.